Murnane, P. M., Strehlau, R., Shiau, S., Patel, F., Mbete, N., Hunt, G., . . . Kuhn, L. (2017). Switching to Efavirenz Versus Remaining on Ritonavir-boosted Lopinavir in Human Immunodeficiency Virus-infected Children Exposed to Nevirapine: Long-term Outcomes of a Randomized Trial. Clin Infect Dis.
Chicago-стиль цитированияMurnane, Pamela M., Renate Strehlau, Stephanie Shiau, Faeezah Patel, Ndileke Mbete, Gillian Hunt, Elaine J. Abrams, Ashraf Coovadia, and Louise Kuhn. "Switching to Efavirenz Versus Remaining On Ritonavir-boosted Lopinavir in Human Immunodeficiency Virus-infected Children Exposed to Nevirapine: Long-term Outcomes of a Randomized Trial." Clin Infect Dis 2017.
MLA-цитированиеMurnane, Pamela M., et al. "Switching to Efavirenz Versus Remaining On Ritonavir-boosted Lopinavir in Human Immunodeficiency Virus-infected Children Exposed to Nevirapine: Long-term Outcomes of a Randomized Trial." Clin Infect Dis 2017.